-
1
-
-
0036251569
-
Hepatotoxicity of commonly used drugs: nonsteroidal anti-inflammatory drugs, antihypertensives, antidiabetic agents, anticonvulsants, lipid-lowering agents, psychotropic drugs
-
Chitturi S, George J. Hepatotoxicity of commonly used drugs: nonsteroidal anti-inflammatory drugs, antihypertensives, antidiabetic agents, anticonvulsants, lipid-lowering agents, psychotropic drugs. Semin. Liver Dis. 2002; 22: 169-83.
-
(2002)
Semin. Liver Dis.
, vol.22
, pp. 169-183
-
-
Chitturi, S.1
George, J.2
-
2
-
-
7744220837
-
Prescription of statins to dyslipidemic patients affected by liver diseases: a subtle balance between risks and benefits
-
Anfossi G, Massucco P, Bonomo K, Trovati M. Prescription of statins to dyslipidemic patients affected by liver diseases: a subtle balance between risks and benefits. Nutr. Metab. Cardiovasc. Dis. 2004; 14: 215-24.
-
(2004)
Nutr. Metab. Cardiovasc. Dis.
, vol.14
, pp. 215-224
-
-
Anfossi, G.1
Massucco, P.2
Bonomo, K.3
Trovati, M.4
-
5
-
-
0037013571
-
Cholestasis associated with the use of pravastatin sodium
-
Batey RG, Harvey M. Cholestasis associated with the use of pravastatin sodium. Med. J. Aust. 2002; 176: 561-3.
-
(2002)
Med. J. Aust.
, vol.176
, pp. 561-563
-
-
Batey, R.G.1
Harvey, M.2
-
6
-
-
77249100776
-
Atorvastatin-induced prolonged cholestasis with bile duct damage
-
Merli M, Bragazzi MC, Giubilo F, Callea F, Attili AF, Alvaro D. Atorvastatin-induced prolonged cholestasis with bile duct damage. Clin. Drug Investig. 2010; 30: 205-9.
-
(2010)
Clin. Drug Investig.
, vol.30
, pp. 205-209
-
-
Merli, M.1
Bragazzi, M.C.2
Giubilo, F.3
Callea, F.4
Attili, A.F.5
Alvaro, D.6
-
7
-
-
58149507709
-
Severe acute cholestatic hepatitis with prolonged cholestasis and bile-duct injury following atorvastatin therapy: a case report
-
Rahier JF, Rahier J, Leclercq I, Geubel AP. Severe acute cholestatic hepatitis with prolonged cholestasis and bile-duct injury following atorvastatin therapy: a case report. Acta Gastroenterol. Belg. 2008; 71: 318-20.
-
(2008)
Acta Gastroenterol. Belg.
, vol.71
, pp. 318-320
-
-
Rahier, J.F.1
Rahier, J.2
Leclercq, I.3
Geubel, A.P.4
-
8
-
-
0035991457
-
Acute cholestatic hepatitis after reinitiating treatment with atorvastatin
-
Ridruejo E, Mando OG. Acute cholestatic hepatitis after reinitiating treatment with atorvastatin. J. Hepatol. 2002; 37: 165-6.
-
(2002)
J. Hepatol.
, vol.37
, pp. 165-166
-
-
Ridruejo, E.1
Mando, O.G.2
-
9
-
-
0033598106
-
Atorvastatin-induced cholestatic hepatitis in a young woman with systemic lupus erythematosus
-
Jiminez-Alonso J, Osorio JM, Gutierrez-Cabello F, Lopez de la Osa A, Leon L, Garcia JDM. Atorvastatin-induced cholestatic hepatitis in a young woman with systemic lupus erythematosus. Arch. Intern. Med. 1999; 159: 1811-12.
-
(1999)
Arch. Intern. Med.
, vol.159
, pp. 1811-1812
-
-
Jiminez-Alonso, J.1
Osorio, J.M.2
Gutierrez-Cabello, F.3
Lopez de la Osa, A.4
Leon, L.5
Garcia, J.D.M.6
-
10
-
-
77954424607
-
Statins in primary biliary cirrhosis: are they safe?
-
Rajab MA, Kaplan MM. Statins in primary biliary cirrhosis: are they safe? Dig. Dis. Sci. 2010; 55: 2086-8.
-
(2010)
Dig. Dis. Sci.
, vol.55
, pp. 2086-2088
-
-
Rajab, M.A.1
Kaplan, M.M.2
-
11
-
-
77049089696
-
Low-dose atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis after one year of treatment
-
Stojakovic T, Thierry C, Putz-Bankuti C etal. Low-dose atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis after one year of treatment. Atherosclerosis 2010; 209: 178-83.
-
(2010)
Atherosclerosis
, vol.209
, pp. 178-183
-
-
Stojakovic, T.1
Thierry, C.2
Putz-Bankuti, C.3
-
12
-
-
0027370470
-
Experimental use of pravastatin in patients with primary biliary cirrhosis associated with hypercholesterolemia
-
Kurihara T, Akimoto M, Abe K etal. Experimental use of pravastatin in patients with primary biliary cirrhosis associated with hypercholesterolemia. Clin. Ther. 1993; 15: 890-8.
-
(1993)
Clin. Ther.
, vol.15
, pp. 890-898
-
-
Kurihara, T.1
Akimoto, M.2
Abe, K.3
-
13
-
-
0029055416
-
Marked improvement in cholestasis and hypercholesterolemia with simvastatin in a patient with primary biliary cirrhosis
-
Kamisako T, Adachi Y. Marked improvement in cholestasis and hypercholesterolemia with simvastatin in a patient with primary biliary cirrhosis. Am. J. Gastroenterol. 1995; 90: 1187-8.
-
(1995)
Am. J. Gastroenterol.
, vol.90
, pp. 1187-1188
-
-
Kamisako, T.1
Adachi, Y.2
-
14
-
-
0036102527
-
Simvastatin in primary biliary cirrhosis: effects on serum lipids and distinct disease markers
-
Ritzel U, Leonardt U, Nather M, Schafer G, Armstrong VW, Ramadori G. Simvastatin in primary biliary cirrhosis: effects on serum lipids and distinct disease markers. J. Hepatol. 2002; 36: 454-8.
-
(2002)
J. Hepatol.
, vol.36
, pp. 454-458
-
-
Ritzel, U.1
Leonardt, U.2
Nather, M.3
Schafer, G.4
Armstrong, V.W.5
Ramadori, G.6
-
15
-
-
48349115722
-
Treatment of hypercholesterolemia in patients with primary biliary cirrhosis may be more beneficial than indicated
-
Balmer ML, Dufour J-F. Treatment of hypercholesterolemia in patients with primary biliary cirrhosis may be more beneficial than indicated. Swiss Med. Wkly. 2008; 138: 415-19.
-
(2008)
Swiss Med. Wkly.
, vol.138
, pp. 415-419
-
-
Balmer, M.L.1
Dufour, J.-F.2
-
16
-
-
44449143344
-
Atorvastatin does not improve liver biochemistries or Mayo risk score in primary biliary cirrhosis
-
Stanca CM, Bach N, Allina J, Bodian C, Bodenheimer H, Odin JA. Atorvastatin does not improve liver biochemistries or Mayo risk score in primary biliary cirrhosis. Dig. Dis. Sci. 2008; 53: 1988-93.
-
(2008)
Dig. Dis. Sci.
, vol.53
, pp. 1988-1993
-
-
Stanca, C.M.1
Bach, N.2
Allina, J.3
Bodian, C.4
Bodenheimer, H.5
Odin, J.A.6
-
17
-
-
34548758431
-
Atorvastatin in patients with primary biliary cirrhosis and incomplete biochemical response to ursodeoxycholic acid
-
Stojakovic T, Putz-Bankuti C, Fauler G etal. Atorvastatin in patients with primary biliary cirrhosis and incomplete biochemical response to ursodeoxycholic acid. Hepatology 2007; 46: 776-84.
-
(2007)
Hepatology
, vol.46
, pp. 776-784
-
-
Stojakovic, T.1
Putz-Bankuti, C.2
Fauler, G.3
-
18
-
-
3042620358
-
Cholestasis: human disease and experimental animal models
-
Rodriguez-Garay EA. Cholestasis: human disease and experimental animal models. Ann. Hepatol. 2003; 2: 150-8.
-
(2003)
Ann. Hepatol.
, vol.2
, pp. 150-158
-
-
Rodriguez-Garay, E.A.1
-
19
-
-
77951561501
-
Nuclear receptor regulation of the adaptive response of bile acid transporters in cholestasis
-
Wagner M, Zollner G, Trauner M. Nuclear receptor regulation of the adaptive response of bile acid transporters in cholestasis. Semin. Liver Dis. 2010; 30: 160-77.
-
(2010)
Semin. Liver Dis.
, vol.30
, pp. 160-177
-
-
Wagner, M.1
Zollner, G.2
Trauner, M.3
-
20
-
-
77950851232
-
Effect of rosuvastatin on cholestasis-induced hepatic injury in rat livers
-
Awad AS, Kamel R. Effect of rosuvastatin on cholestasis-induced hepatic injury in rat livers. J. Biochem. Mol. Toxicol. 2010; 24: 89-94.
-
(2010)
J. Biochem. Mol. Toxicol.
, vol.24
, pp. 89-94
-
-
Awad, A.S.1
Kamel, R.2
-
21
-
-
65449171213
-
Simvastatin protects against cholestasis-induced liver injury
-
Dold S, Laschke MW, Lavasani S, Menger MD, Jeppsson B, Thorlacius H. Simvastatin protects against cholestasis-induced liver injury. Br. J. Pharmacol. 2009; 156: 466-74.
-
(2009)
Br. J. Pharmacol.
, vol.156
, pp. 466-474
-
-
Dold, S.1
Laschke, M.W.2
Lavasani, S.3
Menger, M.D.4
Jeppsson, B.5
Thorlacius, H.6
-
22
-
-
33846585018
-
Fluvastatin reduced liver injury in rat model of extrahepatic cholestasis
-
Demirbilek S, Tas E, Gurunluoglu K etal. Fluvastatin reduced liver injury in rat model of extrahepatic cholestasis. Pediatr. Surg. Int. 2007; 23: 155-62.
-
(2007)
Pediatr. Surg. Int.
, vol.23
, pp. 155-162
-
-
Demirbilek, S.1
Tas, E.2
Gurunluoglu, K.3
-
23
-
-
79958263832
-
Role of nuclear receptors for bile acid metabolism, bile secretion, cholestasis, and gallstone disease
-
Claudel T, Zollner G, Wagner M, Trauner M. Role of nuclear receptors for bile acid metabolism, bile secretion, cholestasis, and gallstone disease. Biochim. Biophys. Acta 2011; 1812: 867-78.
-
(2011)
Biochim. Biophys. Acta
, vol.1812
, pp. 867-878
-
-
Claudel, T.1
Zollner, G.2
Wagner, M.3
Trauner, M.4
-
24
-
-
79952227694
-
Nuclear receptors in liver disease
-
Wagner M, Zollner G, Trauner M. Nuclear receptors in liver disease. Hepatology 2011; 53: 1023-34.
-
(2011)
Hepatology
, vol.53
, pp. 1023-1034
-
-
Wagner, M.1
Zollner, G.2
Trauner, M.3
-
25
-
-
79953173235
-
Nuclear receptors as new perspective for the management of liver diseases
-
Trauner M, Halilbasic E. Nuclear receptors as new perspective for the management of liver diseases. Gastroenterology 2011; 140: 1120-5.
-
(2011)
Gastroenterology
, vol.140
, pp. 1120-1125
-
-
Trauner, M.1
Halilbasic, E.2
-
26
-
-
80053099585
-
Pravastatin modulates liver bile acid and cholesterol homeostasis in rats with chronic cholestasis
-
Kolouchova G, Brcakova E, Hirsova P etal. Pravastatin modulates liver bile acid and cholesterol homeostasis in rats with chronic cholestasis. J. Gastroenterol. Hepatol. 2011; 26: 1544-51.
-
(2011)
J. Gastroenterol. Hepatol.
, vol.26
, pp. 1544-1551
-
-
Kolouchova, G.1
Brcakova, E.2
Hirsova, P.3
|